Surgical treatment of hypopharyngeal cancer

Yıl 2018, Cilt: 28 Sayı: 3, 105 - 111, 20.09.2018

Selçuk Güneş Bora Başaran İsmet Aslan Ökkeş Erkan Kıyak

Öz

Objectives: This study aims to evaluate our department’s approach to the treatment of hypopharyngeal tumors, the features of the tumors, the survival analyses and to present our results in the light of the literature. Patients and Methods: Eighty-one hypopharyngeal tumor patients and four patients with undefined primary origin, those patients with undefined origin have tumors that infiltrate both hypopharynx and cervical esophagus, totally 85 patients 56 males, 29 females; mean age 54.6±13.4 years; range, 23 to 81 years who underwent surgical treatment, were included in this study. Demographic data, tumor characteristics, and treatment protocols were recorded retrospectively. Results: Patients were classified on the primary subsite of the hypopharynx: 51% originated from the sinus piriformis, 29% from the postcricoid area, 15% from the posterior wall of the pharynx and only 5% from the cervical esophagus. The relationship between sex and hypopharyngeal subsite was statistically significant p<0.001 ; postcricoid tumors were more prominent in female patients. Also, patients with a history of tobacco use had a tendency for tumors originating from the piriform sinus p<0.001 . Additionally, highly significant differences were revealed between clinical and pathological T and N staging p<0.001 . Estimated 60-month survival rate was 45%. Conclusion: The majority of patients in the study group were not old-aged or alcohol consumers; particularly none of the female patients had any bad habit as a predisposing factor suggested in the etiology. The relationships between tumor site and smoking show that if the campaign against smoking is successful, the rate of sinus piriformis cancer will decrease. For a significant number of patients, primary surgical reconstruction was possible, which shortens postoperative recovery time and accelerates postoperative adjuvant therapy. Therefore, survival rates were found to be high.

Anahtar Kelimeler

Esophageal reconstruction, hypopharynx cancer, organ preservation surgery, surgical treatment, survival

Kaynakça

• Gourin CG, Terris DJ. Carcinoma of the hypopharynx. Surg Oncol Clin N Am 2004;13:81-98.
• Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009;31:748-58.
• Popescu CR, Bertesteanu SV, Mirea D, Grigore R, lonescu D, Popescu B. The epidemiology of hypopharynx and cervical esophagus cancer. J Med Life 2010;3:396-401.
• Raghavan U, Quraishi S, Bradley PJ. Multiple primary tumors in patients diagnosed with hypopharyngeal cancer. Otolaryngol Head Neck Surg 2003;128:419-25.
• Kraus DH, Zelefsky MJ, Brock HAJ, Huo J, Harrison LB, Shah JP. Combined Surgery and Radiation Therapy for Squamous Cell Carcinoma of the Hypopharynx. Otolaryngol Head Neck Surg 1997;116:637-641.
• Iwae S, Fujii M, Hayashi R, Hasegawa Y, Fujii T, Okami K, et al. Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy. Int J Clin Oncol 2017;22:1001-1008.
• Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol Head Neck Surg 2001;124:561-9.
• Sewnaik A, Hoorweg JJ, Knegt PP, Wieringa MH, van der Beek JM, Kerrebijn JD. Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period. Clin Otolaryngol 2005;30:52-7.
• Gupta T, Chopra S, Agarwal JP, Laskar SG, D’cruz AK, Shrivastava SK, et al. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non- surgical approaches. Acta Oncol 2009;48:541-48.
• National Comprehensive Cancer Network. NCCN. Guidelines Head and Neck Version 1.2015. Available at: www.nccn.org.
• Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001;111:1079-87.
• Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9.
• Beauvillain C, Mahé M, Bourdin S, Peuvrel P, Bergerot P, Rivière A, et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 1997;107:648-53.
• Hall SF, Groome PA, Irish J, O’Sullivan B. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 2008;118:1362-71.
• Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE. Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 1987;60:1178-83.
• Kim KH, Sung MW, Rhee CS, Koo JW, Koh TY, Lee DW, et al. Neoadjuvant chemotherapy and radiotherapy for the treatment of advanced hypopharyngeal carcinoma. Am J Otolaryngol 1998;19:40-4.
• Chu PY, Wang LW, Chang SY. Surgical treatment of squamous cell carcinoma of the hypopharynx: analysis of treatment results, failure patterns, and prognostic factors. J Laryngol Otol 2004;118:443-9.
• Johnson JT, Bacon GW, Myers EN, Wagner RL. Medial vs lateral wall pyriform sinus carcinoma: implications for management of regional lymphatics. Head Neck 1994;16:401-5.
• Haller JR. Concepts in pharyngoesophageal reconstruction. Otolaryngol Clin North Am 1997;30:655-61.